Cirrhosis and portal hypertension

USG · CT

First and second year — the floor first, then every step

Describe the liver (surface nodularity, caudate hypertrophy), then the signs of portal hypertension — spleen size, portal vein flow direction and velocity, collaterals, ascites — and survey for hepatocellular carcinoma.

Orient first

  • Imaging can suggest cirrhosis but early cirrhosis may look normal; elastography measures stiffness.
  • Portal hypertension shows as splenomegaly, portosystemic collaterals (left gastric, paraumbilical, splenorenal), ascites and slow or reversed portal flow.
  • Every cirrhotic liver on imaging is also a surveillance study for hepatocellular carcinoma — report any observation.

Acquire the study

  • Curvilinear probe for the liver surface and spleen; a linear high-frequency probe for surface nodularity; spectral Doppler of the portal vein at the porta.

The manoeuvre

  • Liver surface with the linear probe: nodularity; caudate lobe enlargement relative to the right lobe.
  • Portal vein at the porta on spectral Doppler: direction (hepatopetal or hepatofugal), velocity and calibre in mm.
  • Spleen length in cm; the splenic vein.
  • Collaterals on colour Doppler: recanalised paraumbilical vein, splenorenal shunt; ascites.
  • Hepatic veins: phasicity (lost in cirrhosis) and patency (Budd–Chiari).

What confirms it

  • Morphological features of cirrhosis with the portal hypertension signs present or absent.

What licenses you to exclude it

  • A normal ultrasound does not exclude cirrhosis; elastography or biopsy is needed when the question matters.

The classic misread

  • Calling hepatofugal flow normal because the colour map was not checked against the probe direction.

See it on real cases

Direct links to Radiopaedia — the reference article and worked cases with their images. Each opens on Radiopaedia.

Key papers

Reviews and guidelines from RSNA, ESR and related journals. Each opens at its DOI.

  1. Noninvasive diagnosis of liver cirrhosis: qualitative and quantitative imaging biomarkers ↗Zheng T, Qu Y, Chen J, et al. · Abdominal Radiology 2024SAR · PubMed
  2. Noninvasive imaging assessment of portal hypertension ↗Kennedy P, Bane O, Hectors SJ, et al. · Abdominal Radiology 2020SAR · PubMed
  3. Non-invasive evaluation of liver cirrhosis using ultrasound ↗Goyal N, Jain N, Rachapalli V, et al. · Clinical Radiology 2009RCR · PubMed
  4. Imaging of spontaneous portosystemic shunts in portal hypertension: clinical significance and structured reporting ↗de Paiva Guimarães Barreiro T, Golfi JE, Penachim TJ, et al. · Abdominal Radiology 2026SAR · PubMed

More searches

More in Abdomen and pelvis